The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s IMAAVY (nipocalimab-aahu), a human FcRn-blocking ...

MitoRx Therapeutics Limited, a platform biotech company, has appointed Xavier Jacq as Chief Scientific Officer (CSO).

The global pharmaceutical supply chain is a complex network vital for patient health, and its components are undergoing a ...

Symbiosis Pharmaceutical Services passed its recent audit conducted by the UK’s Medicines and Healthcare products Regulatory ...

L7 Informatics’ Marcia Blackmoore on how structured data, digital workflows, and real-time orchestration are helping CDMOs deliver at scale without compromising quality.

The U.S. Food and Drug Administration (FDA) has approved Abeona Therapeutics Inc.’s ZEVASKYN gene-modified cellular sheets.